Cosmo Pharmaceuticals Investor Relations Material
Latest events
H2 2023
Cosmo Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Cosmo Pharmaceuticals N.V.
Access all reports
Established in 1997, Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. The company offers drug delivery systems primarily rectal, topical, oral, nasal wafer based systems. Cosmo Pharmaceuticals aims to become a global leader in optimized therapies for selected gastroenterology and colorectal disease areas by leveraging its proprietary and differentiated technology.
Key slides for Cosmo Pharmaceuticals N.V.
H1 2023
Cosmo Pharmaceuticals N.V.
H2 2023
Cosmo Pharmaceuticals N.V.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇨🇭 Switzerland